[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2915378B1 - USE OF AN ACTIVE INGREDIENT FROM SOYBEANS (GLYCINE MAX L.) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA - Google Patents

USE OF AN ACTIVE INGREDIENT FROM SOYBEANS (GLYCINE MAX L.) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA

Info

Publication number
FR2915378B1
FR2915378B1 FR0703050A FR0703050A FR2915378B1 FR 2915378 B1 FR2915378 B1 FR 2915378B1 FR 0703050 A FR0703050 A FR 0703050A FR 0703050 A FR0703050 A FR 0703050A FR 2915378 B1 FR2915378 B1 FR 2915378B1
Authority
FR
France
Prior art keywords
soybeans
preparing
active ingredient
glycine max
composition intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0703050A
Other languages
French (fr)
Other versions
FR2915378A1 (en
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincience SA filed Critical Vincience SA
Priority to FR0703050A priority Critical patent/FR2915378B1/en
Publication of FR2915378A1 publication Critical patent/FR2915378A1/en
Application granted granted Critical
Publication of FR2915378B1 publication Critical patent/FR2915378B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
FR0703050A 2007-04-27 2007-04-27 USE OF AN ACTIVE INGREDIENT FROM SOYBEANS (GLYCINE MAX L.) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA Expired - Fee Related FR2915378B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0703050A FR2915378B1 (en) 2007-04-27 2007-04-27 USE OF AN ACTIVE INGREDIENT FROM SOYBEANS (GLYCINE MAX L.) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0703050A FR2915378B1 (en) 2007-04-27 2007-04-27 USE OF AN ACTIVE INGREDIENT FROM SOYBEANS (GLYCINE MAX L.) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA

Publications (2)

Publication Number Publication Date
FR2915378A1 FR2915378A1 (en) 2008-10-31
FR2915378B1 true FR2915378B1 (en) 2009-08-21

Family

ID=38740544

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0703050A Expired - Fee Related FR2915378B1 (en) 2007-04-27 2007-04-27 USE OF AN ACTIVE INGREDIENT FROM SOYBEANS (GLYCINE MAX L.) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA

Country Status (1)

Country Link
FR (1) FR2915378B1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2938766B1 (en) * 2008-11-26 2010-12-31 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING VINE LEAF HYDROLYSAT (VITIS VINIFERA L.) AS ACONITASE ACTIVATOR ACTIVE INGREDIENT AND MITOCHONDRIA PROTECTOR
FR2943542B1 (en) * 2009-03-31 2012-05-25 Lvmh Rech METHOD OF ANTI-AGE COSMETIC CARE BY STIMULATING THE ACTIVITY OF MITOCHONDRIAL ACONISATE
FR2944017B1 (en) 2009-04-02 2012-03-09 Isp Investments Inc NOVEL PROTEASOME ACTIVATORY LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME
FR2944018B1 (en) 2009-04-02 2012-03-09 Isp Investments Inc NOVEL PROTEASOME ACTIVATOR ANTI-AGING PEPTIDES AND COMPOSITIONS CONTAINING SAME
FR2944795B1 (en) * 2009-04-23 2013-08-02 Isp Investments Inc PEPTIDE HYDROLYSATS ACTIVATORS OF PROTEASOME AND COMPOSITIONS CONTAINING SAME
FR2944796B1 (en) * 2009-04-23 2013-08-02 Isp Investments Inc PEPTIDE HYDROLYSATS LIGHTENING PROTEASOME ACTIVATORS AND COMPOSITIONS CONTAINING SAME
FR2944797B1 (en) * 2009-04-23 2013-05-10 Isp Investments Inc PEPTIDE HYDROLYSATS ACTIVATORS OF PROTEASOME AND COMPOSITIONS CONTAINING SAME
FR2944798B1 (en) * 2009-04-23 2013-05-10 Isp Investments Inc PEPTIDE HYDROLYSATS LIGHTENING PROTEASOME ACTIVATORS AND COMPOSITIONS CONTAINING SAME
FR2987998B1 (en) 2012-03-19 2014-04-25 Isp Investments Inc COSMETIC COMPOSITION COMPRISING A SYNERGISTIC ACTION TRF2 PROTEIN ACTIVATION SYSTEM COMPRISING AN ASSOCIATION OF PEPTIDE EXTRACT OF SOY AND YEAST AND USES THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
US8431550B2 (en) * 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
EP1368017A2 (en) * 2001-02-14 2003-12-10 Matthias Rath Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
FR2854069B1 (en) * 2003-04-23 2006-03-10 Silab Sa PROCESS FOR OBTAINING AN ACTIVE INGREDIENT FROM SOYBEANS, HAVING ANTI-AGING PROPERTIES, COMPOSITIONS AND USES OF SAID COSMETIC COMPOSITIONS
EP1789030A2 (en) * 2004-08-30 2007-05-30 Interstitial Therapeutics Medical implant provided with inhibitors of atp synthesis

Also Published As

Publication number Publication date
FR2915378A1 (en) 2008-10-31

Similar Documents

Publication Publication Date Title
FR2915378B1 (en) USE OF AN ACTIVE INGREDIENT FROM SOYBEANS (GLYCINE MAX L.) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA
FR2915381B1 (en) USE OF AN ACTIVE INGREDIENT FROM SOYBEANS (GLYCINE MAX L) TO PREPARE A COMPOSITION FOR ACTIVATING CYTOCHROME C
FR2915384B1 (en) USE OF AN ACTIVE INGREDIENT FROM SOYBEANS (GLYCINE MAXL.) FOR PREPARING A COMPOSITION FOR ACTIVATING CELL ENERGY AND PROTECTING THE SKIN FROM OXIDATIVE DAMAGE.
BRPI0923728A2 (en) "Method of preparing dihydroindene amide compounds, their pharmaceutical compositions containing such compounds and use as a protein kinase inhibitor."
FR2918893B1 (en) USE OF AN ACTIVE INGREDIENT FROM LINING TO PREPARE A COMPOSITION FOR ACTIVATING CYTOCHROME C
ECSP109922A (en) PIRAZOL COMPOUNDS AND ITS USE AS RAF INHIBITORS
NI201200168A (en) PHARMACEUTICAL FORMULATIONS
UA111343C2 (en) Pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride
MX2007012732A (en) Azole derivatives in the form of lipase and phospholipase inhibitors.
FR2915379B1 (en) USE OF AN ACTIVE INGREDIENT FROM RICE (ORYZA SATIVA L) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA
HN2009000455A (en) QUINASA INHIBIDORE
GT200900292A (en) "KINASE INHIBITORS P70 S6"
ZA200810006B (en) Low-foaming preparations for crop protection
CR11252A (en) NEW DERIVATIVES OF 6-TRIAZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS
CL2007002242A1 (en) ORAL PHARMACEUTICAL DOSAGE FORM IN COMPRESSED, CAPSULA OR GRANULUM, INCLUDING BIS- (MONOETHANOLAMINE) OF ACID 3 '- [(2Z) - [1- (3,4-DIMETHYLPHENYL) -1,5-DIHYDRO-3-METHYL-5 -OXO-4H-PIRAZOL-4-ILIDENO] HYDRAZINO] -2'-HYDROXY [1-1'-BIFENYL] -3-CARBOXYL; PRO
PL2389073T3 (en) Making a soluble soy protein product from the micellar mass of soy protein ("S200Ca")
CR10479A (en) VR1 BENCIMIDAZOLIC MODULARS
GT200800251A (en) SIPROCICLIC NITRILS AS PROTEASA INHIBITORS
CO6612255A2 (en) Salts of 4- [2 - [[5-methyl-1- (2-naphthalenyl) -1h-pyrazol-3-yl] oxy] eyl] morpholine
EP2364157A4 (en) PLANT EXTRACT COMPOSITIONS FOR AFFECTING SLEEP
EA201000814A1 (en) 5 - [(3,3,3-TRIFTOR-2-HYDROXY-1-ARYLPROPIL) AMINO] -1H-QUINOLIN-2-ONE, METHOD OF THEIR RECEIVING AND THEIR APPLICATION AS ANTI-INFLAMMATORY MEANS
MA32834B1 (en) Aminocyclopentaneicarboxamide 3 acts as a shimokin receptor modulator
WO2009095098A3 (en) Use of benzothiadiazoles
FR2851287B1 (en) ANNULAR DISPENSER PLATFORM FOR TURBOMACHINE LOW PRESSURE TURBINE
EA201000703A1 (en) DERIVATIVES OF PYRAZOL AS A 5-LO INHIBITORS

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20151231